J 2024

Testing of the Czech questionnaire for identifying children at risk of obstructive sleep apnea

MARINČÁK VRANKOVÁ, Zuzana; Tomáš KRATOCHVÍL; Maria Pia VILLA a Petra BOŘILOVÁ LINHARTOVÁ

Základní údaje

Originální název

Testing of the Czech questionnaire for identifying children at risk of obstructive sleep apnea

Vydání

Nature Scientific Reports, London, NATURE RESEARCH, 2024, 2045-2322

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

10700 1.7 Other natural sciences

Stát vydavatele

Německo

Utajení

není předmětem státního či obchodního tajemství

Odkazy

Impakt faktor

Impact factor: 3.900

Označené pro přenos do RIV

Ano

Kód RIV

RIV/00216224:14310/24:00137136

Organizační jednotka

Přírodovědecká fakulta

EID Scopus

Klíčová slova anglicky

Questionnaire; Pediatric obstructive sleep apnea; Validation; Likert scale; Apnea-hypopnea index; Risk factor

Štítky

Příznaky

Mezinárodní význam, Recenzováno
Změněno: 25. 2. 2025 16:19, Mgr. Michaela Hylsová, Ph.D.

Anotace

V originále

This study aimed to create a Czech questionnaire for pediatric obstructive sleep apnea (POSA) risk screening, a first of its kind in the Czech Republic, where options for child polysomnography are limited. Compiling items from established English questionnaires and supplementing them with additional items, we designed the first version of the Czech questionnaire and tested it in a pilot study with parents of 30 children. After pilot feedback, a revised version with dichotomous and 5-item Likert scale questions was tested on 71 children's parents. All children (7-12 years old) underwent a home sleep apnea test to record their apnea-hypopnea index (AHI). The second (40-item) version showed high reliability (93%), with 17 items identified as the most significant. Findings from the final 17-item SEN CZ questionnaire correlated positively with AHI (p < 0.001), demonstrating 84% sensitivity, 86% specificity, and 93% reliability. Three factors, namely breathing problems, inattention, and hyperactivity (characterized by multiple items), were identified to form a higher-order factor of POSA risk, which was further supported by the correlations of their total scores with AHI (p < 0.001). The resulting SEN CZ questionnaire can serve as a tool for POSA risk screening in the Czech Republic without the need to involve medical professionals.

Návaznosti

EF17_043/0009632, projekt VaV
Název: CETOCOEN Excellence
857560, interní kód MU
(Kód CEP: EF17_043/0009632)
Název: CETOCOEN Excellence (Akronym: CETOCOEN Excellence)
Investor: Evropská unie, CETOCOEN Excellence, Spreading excellence and widening participation
90269, velká výzkumná infrastruktura
Název: RECETOX RI II

Přiložené soubory